1. Home
  2. AZTR vs BOXL Comparison

AZTR vs BOXL Comparison

Compare AZTR & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.17

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Boxlight Corporation

BOXL

Boxlight Corporation

HOLD

Current Price

$4.73

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
BOXL
Founded
2014
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
AZTR
BOXL
Price
$0.17
$4.73
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.1M
34.0K
Earning Date
05-08-2026
04-16-2026
Dividend Yield
N/A
N/A
EPS Growth
5.06
N/A
EPS
N/A
N/A
Revenue
N/A
$25,743,612.00
Revenue This Year
N/A
$2.70
Revenue Next Year
N/A
$5.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.37
52 Week Low
$0.10
$0.50
52 Week High
$1.09
$9.89

Technical Indicators

Market Signals
Indicator
AZTR
BOXL
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
AZTR
BOXL

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

Share on Social Networks: